This inventor holds 1 USPTO granted patent. Top assignee: British Biotech Pharmaceuticals Limited. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: The Innovations of Karen Margrete Miller
Introduction
Karen Margrete Miller is a notable inventor based in Oxford, GB. She has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. Her work focuses on the use of matrix metalloprotease (MMP) inhibitors, which have shown promise in promoting tumor regression and inhibiting cancer cell proliferation.
Latest Patents
Karen holds 1 patent related to her innovative research. The patent details the use of various known compounds that act as MMP inhibitors, highlighting their potential in developing agents for cancer therapy.
Career Highlights
Karen is currently employed at British Biotech Pharmaceuticals Limited, where she continues to advance her research in the pharmaceutical industry. Her expertise in MMP inhibitors has positioned her as a key figure in the development of new cancer treatments.
Collaborations
Throughout her career, Karen has collaborated with esteemed colleagues such as Peter Duncan Brown and Lindsay Jayne Bawden. These partnerships have enhanced her research and contributed to the advancement of innovative cancer therapies.
Conclusion
Karen Margrete Miller's work exemplifies the impact of innovative research in the fight against cancer. Her contributions to the field through her patent and collaborations are paving the way for future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile